Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

mint Lesion™ 3.8. Release: What’s New?

The recent 3.8 release brings with it a multitude of new features and refinements that further facilitate reporting, interdisciplinary collaboration, and patient management in clinical routine and clinical trials. Users worldwide can now benefit from multiple general innovations within the software platform as well as specific updates concerning radiomics, various reading templates, and evaluation criteria, e.g. PI-RADS or TNM 8.0.
 
mint Lesion™ enables its users to see the big picture, to leave no data behind on the image with its one of a kind read process which directly links any findings to the imaging data. New changes in the user interface, such as directly available information in the read screen on historic values of all measurements and user-defined answers via tables and charts, provide the user with all information necessary for a holistic read process. To advance this process, a revision of the anatomical location selection dialog improves the readability of long location names, which in turn facilitates the differentiation of major locations from sub-locations.
 
Since we understand radiomics to be the driving force behind the advancement of personalized therapy, further improvements were made in this area: radiomics features can now also be calculated on PET and ADC image measurements, enabling the user to gain valuable information that allows them to potentially decide on the best therapy approach upon the first imaging. Through a new dialog, multiple radiomics exports with differing configurations can be conveniently triggered and used to analyze tumor heterogeneity right from the start. mint Lesion™ supports its users in their radiomics research by collecting radiomics data in the background of their day-to-day reading activity, and these new adaptations, among others, will further empower the collection of valuable data in clinical trials as well as in clinical routine.
 
Additional changes within mint Lesion™ 3.8 include the ability to draw prostate lesions by free-hand contour in the PI-RADS prostate sector map without being limited to ellipse shapes, leading to a more precise indication of the tumor shape itself. Moreover, the head and neck carcinoma staging criteria TNM 8.0 has been added along with rules to calculate the TNM staging categories automatically based on image findings and answers provided in the reading templates – as mint Lesion™ users are accustomed to.
 
In ongoing clinical trials, it is essential to remain flexible. For this reason, it is now also possible by configuration to add an additional trial arm to an already existing trial. The new trial arm will be available for all patients associated with the trial. From now on, users are also able to determine whether patients should be automatically added to a trial based on certain DICOM attribute values.
 
For an overview of all new features and enhancements of the 3.8 release, feel free to contact us.

Related Resources

Related Resources

Medical University of Innsbruck: Radiomic Assessment of Radiation-Induced Alterations of Skeletal Muscle Composition in Head and Neck Squamous Cell Carcinoma within the Currently Clinically Defined Optimal Time Window for Salvage Surgery

This study [1] aimed to examine tissue changes in patients with head and neck squamous cell carcinoma (HNSCC) after primary radiochemotherapy (RCT)…

New Technique Speeds Up Whole-Body MRI for Children Without Sacrificing Image Quality, Study Finds

As we mark Childhood Cancer Awareness Month, we would like to highlight the progress achieved in the realm of cancer diagnostics. A recent study led…

Study Discovers Overdiagnosis of Progressive Cancer in Routine Clinical Evaluations

A recent retrospective study led by Dr. Marilyn J. Siegel and her team at the Washington University School of Medicine in St. Louis has shed light on…